Villafuerte, Julieta .
HRN: 27-87-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/05/2025
10/11/2025
IVTT
4.5g
Q6
Cap-MR- Empirical Escalation
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice
Final appropriateness: Yes
Overall appropriateness: Yes